inspection

Business

Granules India faces US FDA inspection challenges at Gagillapur facility

whatnews.in - December 3, 2024

Pharmaceutical manufacturer Granules India Limited disclosed today that its Gagillapur facility in Hyderabad has been classified as “Official Action Indicated” (OAI) by the...

Business

Biocon shares gain 9 per cent after USFDA inspection of Bengaluru unit

whatnews.in - November 11, 2024

Shares of Biocon gained over 8 per cent after the US Food and Drug Administration (USFDA) classified its Bengaluru unit as voluntary action...

Business

Granules India shares plunge 16% after USFDA inspection ends with 6 observations

whatnews.in - September 12, 2024

Granules India shares plunged over 16 percent during intraday trading on Thursday, September 12, following the company's announcement that the USFDA's inspection of...